tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Acne Vulgaris D000152 35 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adrenal Insufficiency D000309 3 associated lipids
Akinetic Mutism D000405 1 associated lipids
Albuminuria D000419 18 associated lipids
Alopecia D000505 14 associated lipids
Alopecia Areata D000506 6 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amenorrhea D000568 4 associated lipids
Amputation, Traumatic D000673 2 associated lipids
Anemia D000740 21 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Anemia, Hemolytic D000743 4 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Refractory D000753 3 associated lipids
Anemia, Refractory, with Excess of Blasts D000754 2 associated lipids
Aneurysm, Dissecting D000784 2 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Angioedema D000799 6 associated lipids
Anus Diseases D001004 3 associated lipids
Apraxias D001072 1 associated lipids
Arm Injuries D001134 1 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Ascites D001201 25 associated lipids
Ataxia D001259 20 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Autonomic Nervous System Diseases D001342 4 associated lipids
Bacterial Infections D001424 21 associated lipids
Balanitis D001446 4 associated lipids
Beckwith-Wiedemann Syndrome D001506 1 associated lipids
Behcet Syndrome D001528 7 associated lipids
Biliary Fistula D001658 13 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Blepharitis D001762 4 associated lipids
Blindness D001766 6 associated lipids
Body Weight D001835 333 associated lipids
Bone Diseases D001847 4 associated lipids
Bradycardia D001919 13 associated lipids
Brain Diseases D001927 27 associated lipids
Brain Edema D001929 20 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Burns D002056 34 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Cardiomyopathy, Hypertrophic D002312 6 associated lipids
Cardiomyopathy, Restrictive D002313 1 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Carpal Tunnel Syndrome D002349 3 associated lipids
Catalepsy D002375 30 associated lipids
Cataract D002386 34 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Myoclonic Cerebellar Dyssynergia D002527 1 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Uterine Cervical Dysplasia D002578 2 associated lipids
Cheilitis D002613 2 associated lipids
Cholelithiasis D002769 16 associated lipids
Cholestasis D002779 23 associated lipids
Choline Deficiency D002796 16 associated lipids
Hemophilia B D002836 3 associated lipids
Chronic Disease D002908 7 associated lipids
Cicatrix D002921 9 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Collagen Diseases D003095 2 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Confusion D003221 4 associated lipids
Connective Tissue Diseases D003240 2 associated lipids
Corneal Diseases D003316 13 associated lipids
Cough D003371 19 associated lipids
Crigler-Najjar Syndrome D003414 1 associated lipids
Crohn Disease D003424 12 associated lipids
Cryptococcosis D003453 3 associated lipids
Cutis Laxa D003483 1 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cystitis D003556 23 associated lipids
Phyllodes Tumor D003557 1 associated lipids
Hearing Loss, Sudden D003639 1 associated lipids
Deglutition Disorders D003680 2 associated lipids
Dehydration D003681 11 associated lipids
Demyelinating Diseases D003711 15 associated lipids
Dental Enamel Hypoplasia D003744 2 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Dermatitis D003872 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Dury S et al. Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study. 2015 BMC Pulm Med pmid:26545860
Obayashi N et al. Management of tacrolimus-associated food allergy after liver transplantation. 2015 Pediatr Int pmid:26541649
Kwon M et al. Bioequivalence of tacrolimus formulations with different dynamic solubility and in-vitro dissolution profiles. 2015 Arch. Pharm. Res. pmid:24627339
Tang T et al. Roles of the tacrolimus-dependent transcription factor IRF4 in acute rejection after liver transplantation. 2015 Int. Immunopharmacol. pmid:26093273
Hu L et al. Severe Tacrolimus-Induced Granulomatous Rosacea Recalcitrant to Oral Tetracyclines. 2015 J Drugs Dermatol pmid:26091390
Melilli E et al. De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring. 2015 Transpl. Int. pmid:26088437
Traitanon O et al. Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells. 2015 PLoS ONE pmid:26087255
Boukoum H et al. BK and JC polyomavirus infections in Tunisian renal transplant recipients. 2015 J. Med. Virol. pmid:25952258
Rahman S et al. Nordihydroguiaretic acid attenuates skin tumorigenesis in Swiss albino mice with the condition of topical co-administration of an immunosuppressant. 2015 Chem. Biol. Interact. pmid:25770929
Miura M et al. Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts. 2015 Nephrology (Carlton) pmid:26031588
Ma R et al. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression. 2015 Int J Clin Exp Pathol pmid:26823720
Yagisawa T et al. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity. 2015 Nephrology (Carlton) pmid:26031587
Lee J et al. A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk. 2015 J. Korean Med. Sci. pmid:26028917
Mabuchi M et al. Improvement of solid material for affinity resins by application of long PEG spacers to capture the whole target complex of FK506. 2015 Bioorg. Med. Chem. Lett. pmid:26025877
Zhang D et al. Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus. 2015 Mol. Pharm. pmid:26024817
Huang G et al. [Analysis on BK virus associated nephropathy related risk factors in renal transplant recipients]. 2015 Zhonghua Yi Xue Za Zhi pmid:26814103
Kaieda S et al. Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis. 2015 Mod Rheumatol pmid:24252010
Ichimaru N et al. Risk factors and incidence for lipid abnormalities in kidney transplant patients. 2015 Transplant. Proc. pmid:25891708
Lim EJ et al. Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation. 2015 PLoS ONE pmid:26390404
Shu WY et al. Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population. 2015 Acta Pharmacol. Sin. pmid:25891088
Baird K et al. Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. 2015 Biol. Blood Marrow Transplant. pmid:25771402
Kim D et al. Hydrogen sulfide and hypoxia-induced changes in TASK (K2P3/9) activity and intracellular Ca(2+) concentration in rat carotid body glomus cells. 2015 Respir Physiol Neurobiol pmid:25956223
Shuker N et al. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure. 2015 Ther Drug Monit pmid:25265255
Soto GAC et al. Dose increase needed in most cystic fibrosis lung transplantation patients when changing from twice- to once-daily tacrolimus oral administration. 2015 Eur. J. Clin. Pharmacol. pmid:25953736
Wang X et al. Tacrolimus 0.03% ointment in labial discoid lupus erythematosus: A randomized, controlled clinical trial. 2015 J Clin Pharmacol pmid:25951426
Rojas L et al. Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies. 2015 Pharmacogenomics J. pmid:25201288
Ding L et al. Clinical Immunosuppressants Inhibit Inflammatory, Proliferative, and Reprogramming Potential, But Not Angiogenesis of Human Pancreatic Duct Cells. 2015 Cell Transplant pmid:25198311
Chung YW et al. Transcriptional activation of nuclear-related factor 2 by FK506 in Jurkat T cells. 2015 Transplant. Proc. pmid:25891728
Daunton A et al. A cutaneous presentation of a common condition. 2015 BMJ pmid:26681202
Yang SS et al. A single center, open-label, randomized pilot study to evaluate the safety and efficacy of tacrolimus modified release, Advagraf, versus tacrolimus twice daily, Prograf, in stable renal recipients (single). 2015 Transplant. Proc. pmid:25891697
Ã…berg F et al. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report. 2015 Transplant. Proc. pmid:26680092
Rojanathammanee L et al. Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition. 2015 J Neuroinflammation pmid:25889879
Størset E et al. Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study. 2015 Transplantation pmid:25886918
Hempen CM et al. Hematocrit-independent recovery of immunosuppressants from DBS using heated flow-through desorption. 2015 Bioanalysis pmid:26327182
Reig Mezquida JP et al. Thrombotic microangiopathy associated with tacrolimus in lung transplantation. 2015 Arch. Bronconeumol. pmid:25138798
Rajaganapathy BR et al. Intravesical Liposomal Tacrolimus Protects against Radiation Cystitis Induced by 3-Beam Targeted Bladder Radiation. 2015 J. Urol. pmid:25839382
Furlan SN et al. Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention. 2015 Sci Transl Med pmid:26606970
Nagashima T and Minota S Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis. 2015 Rheumatology (Oxford) pmid:25832615
Vollmar J et al. Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan and Mowel after liver transplantation. 2015 Drug Des Devel Ther pmid:26604701
Yasuda S et al. Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis: reply. 2015 Rheumatology (Oxford) pmid:25832614
Eichenfield DZ and Eichenfield LF Pimecrolimus is safe and effective in treating atopic dermatitis. 2015 J. Pediatr. pmid:26603713
Calabrese B and Halpain S Differential targeting of dynamin-1 and dynamin-3 to nerve terminals during chronic suppression of neuronal activity. 2015 Mol. Cell. Neurosci. pmid:25827095
Li Z et al. Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects. 2015 PLoS ONE pmid:26599323
Madariaga ML et al. Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma. 2015 Am. J. Transplant. pmid:25824550
Fujibayashi T et al. Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry. 2015 Mod Rheumatol pmid:25775147
Wang YY et al. Biochemical characterization of a malonyl-specific acyltransferase domain of FK506 biosynthetic polyketide synthase. 2015 Protein Pept. Lett. pmid:25267255
Adotama P et al. Patient satisfaction with different treatment modalities for vitiligo. 2015 J. Am. Acad. Dermatol. pmid:25773415
Cendales L et al. Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report. 2015 Am. J. Transplant. pmid:25773260
Soylu H et al. Survival of renal transplant patients: data from a tertiary care center in Turkey. 2015 Transplant. Proc. pmid:25769571
Boloori A et al. Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients. 2015 PLoS ONE pmid:26551468
Lightman S et al. Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. 2015 Ann. Rheum. Dis. pmid:25269831
Singh N et al. Extended release once a day tacrolimus. 2015 Curr Opin Organ Transplant pmid:26536429
Ohe M and Bohgaki T A Case of Adult-Onset Still's Disease Treated with Monitoring of Serum Tacrolimus Levels. 2015 Bull Hosp Jt Dis (2013) pmid:26535602
Abdel-Azim H et al. Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. 2015 Am. J. Hematol. pmid:26242764
Liu X et al. Associations of HSD11B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients with prednisone combined therapy. 2015 Drug Metab. Dispos. pmid:25587129
Mahajan R et al. Co-localization of agminated congenital melanocytic nevi with vitiligo vulgaris: an unusual presentation. 2015 Int. J. Dermatol. pmid:25039486
Zitelli K et al. Eosinophilic folliculitis occurring after stem cell transplant for acute lymphoblastic leukemia: a case report and review. 2015 Int. J. Dermatol. pmid:25039354
Yokoyama Y et al. Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis. 2015 Mod Rheumatol pmid:25775144
Asrani SK and O'Leary JG Can one pill a day keep rejection away? 2015 Am. J. Transplant. pmid:25703394
Guethoff S et al. De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results. 2015 J. Heart Lung Transplant. pmid:25701373
Pensi D et al. An UPLC-MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells. 2015 J Pharm Biomed Anal pmid:25698619
Kim M et al. Nail lichen striatus: report of seven cases and review of the literature. 2015 Int. J. Dermatol. pmid:26474189
Roche NA et al. Long-Term Multifunctional Outcome and Risks of Face Vascularized Composite Allotransplantation. 2015 J Craniofac Surg pmid:26468783
Peksa GD et al. Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation. 2015 J Oncol Pharm Pract pmid:24938293
Cen J et al. The new immunosuppressant, isogarcinol, binds directly to its target enzyme calcineurin, unlike cyclosporin A and tacrolimus. 2015 Biochimie pmid:25701551
Wang JY and Fan H P70S6 kinase phosphorylation: a new site to assess pharmacodynamy of sirolimus. 2015 Chin. Med. J. pmid:25698201
Mizokami D et al. Tacrolimus prevents laryngotracheal stenosis in an acute-injury rat model. 2015 Laryngoscope pmid:25647147
Ferjani H et al. Tacrolimus and mycophenolate mofetil associations: Induction of oxidative stress or antioxidant effect? 2015 Hum Exp Toxicol pmid:25645822
Rodríguez-Perálvarez M et al. Everolimus is safe within the first month after liver transplantation. 2015 Transpl. Immunol. pmid:26392195
Ishida K et al. Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus. 2015 Drugs R D pmid:26386566
Chow SP et al. Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression. 2015 Cornea pmid:26382894
Ogul H et al. Severe toxic leukoencephalopathy associated with tacrolimus after living donor liver transplantation. 2015 Acta Neurol Belg pmid:24854146
Sato M et al. Multifocal Fibrosclerosis with Hypertrophic Pachymeningitis and a Soft Tissue Mass around the Thoracic Vertebral Bodies: A Case Report with Review of the Literature. 2015 Intern. Med. pmid:26328659
Chittock J et al. Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis. 2015 Acta Derm. Venereol. pmid:25594610
Knops N et al. The functional implications of common genetic variation in CYP3A5 and ABCB1 in human proximal tubule cells. 2015 Mol. Pharm. pmid:25590378
Pallet N et al. Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations. 2015 Am. J. Transplant. pmid:25588704
Ge Y et al. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review. 2015 Clin. Rheumatol. pmid:26328518
Krystel-Whittemore M et al. Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis. 2015 BMJ Case Rep pmid:26318171
Velioglu A et al. Association of BK Virus Titers With Lymphocyte Count in Renal Transplant Patients. 2015 Transplant. Proc. pmid:26093733
Demir T et al. Cancer Screening of Renal Transplant Patients Undergoing Long-Term Immunosuppressive Therapy. 2015 Transplant. Proc. pmid:26093731
Schaap MM et al. A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens. 2015 Arch. Toxicol. pmid:25270620
Yoo MC et al. Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients. 2015 Transplantation pmid:25539464
Offer K et al. Efficacy of tacrolimus/mycophenolate mofetil as acute graft-versus-host disease prophylaxis and the impact of subtherapeutic tacrolimus levels in children after matched sibling donor allogeneic hematopoietic cell transplantation. 2015 Biol. Blood Marrow Transplant. pmid:25536217
Ramachandran R et al. Role of Tacrolimus only therapy in modified Ponticelli regimen resistant idiopathic membranous glomerulonephritis. 2015 Nephrology (Carlton) pmid:25535867
Wardhana EA and Datau A patient with plaque type morphea mimicking systemic lupus erythematosus. 2015 Acta Med Indones pmid:26260557
Aikawa Y et al. Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells. 2015 Cancer Sci. pmid:25529853
Kim SH et al. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients. 2015 HBPD INT pmid:26256081
Ãœnal CM and Steinert M FKBPs in bacterial infections. 2015 Biochim. Biophys. Acta pmid:25529296
Clift DE et al. Effects of embryonic cyclosporine exposures on brain development and behavior. 2015 Behav. Brain Res. pmid:25591474
Joshi S et al. Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal. 2015 Epilepsia pmid:26248944
Duvoux C et al. Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection. 2015 Ann. Transplant. pmid:25588713
Hoerning A et al. Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity. 2015 Transplantation pmid:25099702
Valke LL et al. Soluble CD30 does not predict late acute rejection or safe tapering of immunosuppression in renal transplantation. 2015 Transpl. Immunol. pmid:25446808
Huang G et al. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis. 2015 Diagn. Microbiol. Infect. Dis. pmid:25445121
Spiekerkoetter E et al. Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension. 2015 Am. J. Respir. Crit. Care Med. pmid:26177174
Mandelbrot DA et al. Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus. 2015 Am. J. Transplant. pmid:26176342
Regelmann MO et al. New-onset diabetes mellitus after pediatric liver transplantation. 2015 Pediatr Transplant pmid:26032592
Guo CL et al. Efficacy of Topical Tacrolimus for Erosive Oral Lichen Planus: A Meta-analysis. 2015 Chin. Med. Sci. J. pmid:26960301
Apalla Z et al. Psoriatic cheilitis: a report of 2 cases treated successfully with topical tacrolimus and a review of the literature. 2015 Actas Dermosifiliogr pmid:26164836
Vives R et al. Safety and Activity of UR-1505 in Atopic Dermatitis: A Randomized, Double-blind Phase II Exploratory Trial. 2015 Clin Ther pmid:26163200